Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Schwartz

Showing results (11-20 of 219) with videos related to

Pageof 22
Sort By:
Brain Research Bulletin|March 24, 2004
Optic nerve crush: protection and regenerationMichal Schwartz
Science (New York, N.Y.)|July 22, 2017
Can immunotherapy treat neurodegeneration?Michal Schwartz
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|May 18, 2007
Modulating the immune system: a vaccine for glaucoma?Michal Schwartz
Brain, Behavior, and Immunity|February 13, 2010
"Tissue-repairing" blood-derived macrophages are essential for healing of the injured spinal cord: from skin-activated macrophages to infiltrating blood-derived cells?Michal Schwartz
Trends in Pharmacological Sciences|December 25, 2002
Therapeutic vaccination for spinal cord injury: helping the body to cure itselfEhud Hauben, Michal Schwartz
Trends in Pharmacological Sciences|July 28, 2004
A common vaccine for fighting neurodegenerative disorders: recharging immunity for homeostasisMichal Schwartz, Jonathan Kipnis
The Journal of Pathology|September 26, 2012
Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'Ravid Shechter, Michal Schwartz
Journal of Neurotrauma|April 25, 2006
Immune-based therapy for spinal cord repair: autologous macrophages and beyondMichal Schwartz, Eti Yoles
Neuromolecular Medicine|October 26, 2005
Controlled autoimmunity in CNS maintenance and repair: naturally occurring CD4+CD25+ regulatory T-Cells at the crossroads of health and diseaseJonathan Kipnis, Michal Schwartz
Trends in Immunology|September 13, 2016
Neurological Disease as a Failure of Brain-Immune Crosstalk: The Multiple Faces of NeuroinflammationMichal Schwartz, Aleksandra Deczkowska
Pageof 22

Showing results (11-20 of 219) with videos related to

Sort By:
Pageof 22
Brain Research Bulletin|March 24, 2004
Optic nerve crush: protection and regenerationMichal Schwartz
Science (New York, N.Y.)|July 22, 2017
Can immunotherapy treat neurodegeneration?Michal Schwartz
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|May 18, 2007
Modulating the immune system: a vaccine for glaucoma?Michal Schwartz
Brain, Behavior, and Immunity|February 13, 2010
"Tissue-repairing" blood-derived macrophages are essential for healing of the injured spinal cord: from skin-activated macrophages to infiltrating blood-derived cells?Michal Schwartz
Trends in Pharmacological Sciences|December 25, 2002
Therapeutic vaccination for spinal cord injury: helping the body to cure itselfEhud Hauben, Michal Schwartz
Trends in Pharmacological Sciences|July 28, 2004
A common vaccine for fighting neurodegenerative disorders: recharging immunity for homeostasisMichal Schwartz, Jonathan Kipnis
The Journal of Pathology|September 26, 2012
Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'Ravid Shechter, Michal Schwartz
Journal of Neurotrauma|April 25, 2006
Immune-based therapy for spinal cord repair: autologous macrophages and beyondMichal Schwartz, Eti Yoles
Neuromolecular Medicine|October 26, 2005
Controlled autoimmunity in CNS maintenance and repair: naturally occurring CD4+CD25+ regulatory T-Cells at the crossroads of health and diseaseJonathan Kipnis, Michal Schwartz
Trends in Immunology|September 13, 2016
Neurological Disease as a Failure of Brain-Immune Crosstalk: The Multiple Faces of NeuroinflammationMichal Schwartz, Aleksandra Deczkowska
Pageof 22